Asociación entre el índice de masa corporal aumentado y el ingreso hospitalario por covid-19, en pacientes de un programa de riesgo cardiovascular
DOI:
https://doi.org/10.18041/2665-427X/ijeph.1.7967Palabras clave:
obesidad, COVID-19, Riesgo cardiovascular, sobrepeso, hospitalización, factores de riesgo, admisión hospitalariaResumen
Introducción: Hasta el momento el sobrepeso y la obesidad han sido descritos como factores de riesgo para infectarse, requerir hospitalización y morir por COVID-19. Sin embargo, la literatura no es siempre congruente con estos resultados.
Objetivo: Evaluar el impacto del IMC >25 kg/m2 en el ingreso hospitalario para el manejo de la enfermedad por COVID-19, en pacientes pertenecientes a un programa de riesgo cardiovascular en la ciudad de Cali, Colombia, durante el año 2020.
Métodos: A través de un estudio observacional analítico, se evaluó el riesgo de requerir hospitalización ante la infección por SARS-CoV2 en dos cohortes de pacientes pertenecientes a un programa de riesgo cardiovascular, incluyendo en el grupo expuesto sujetos con IMC >25 kg/m2. Se calculó el riesgo relativo y para evaluar posibles variables confusoras se utilizó el test de homogeneidad de Mantel-Haenszel.
Resultados: El IMC >25 Kg/m2 se encontró como un factor protector para el ingreso hospitalario (RR: 0.5; IC 95%: 0.30-0.80), sin identificarse modificación o confusión en el desenlace por otras variables clínicas como la edad >60 años, el sexo masculino, HTA, DM2 o la obesidad.
Conclusión: el IMC >25 kg/m2 se encontró como un factor protector para el ingreso hospitalario entre pacientes adultos pertenecientes a un programa de riesgo cardiovascular
Descargas
Referencias
Shi F, Wen H, Liu R, Bai J, Wang F, Mubarik S, et al. The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China. Glob Health Res Policy. 2021; 6(1): 18. doi: 10.1186/s41256-021-00200-8.
WHO. Novel Coronavirus(2019-nCoV) Situation Report – 22. Consultado: 2021 Jun 21. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2.
Ministerio del Interior. Decreto numero 00420 del 2020 por el cual se imparten instrucciones para expedir normas en materia de orden público en virtud de la emergencia sanitaria generada por la pandemia de COVID-19. Bogotá: Ministerio del Interior; 2020;
Instituto Nacional de Salud. Módulo de datos COVID-19 en Colombia. Consultado: 2021 Aug 26. Available from: https://www.ins.gov.co/Direcciones/ONS/modelos-covid-19.
Lu Q-B, Zhang H-Y, Che T-L, Zhao H, Chen X, Li R, et al. The differential demographic pattern of Coronavirus Disease 2019 patient fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis. BMC Infect Dis. 2021; 21(1): 481. doi: 10.1186/s12879-021-06187-4.
Kim L, Garg S, O’halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2021; 72(9): e206–e214, https://doi.org/10.1093/cid/ciaa1012.
Wingert A, Pillay J, Gates M, Guitard S, Rahman S, Beck A, et al. Risk factors for severity of COVID-19: a rapid review to inform vaccine prioritisation in Canada. BMJ Open. 2021;11(5):e044684. doi: 10.1136/bmjopen-2020-044684.
Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020; 21(11): e13128. doi: 10.1111/obr.13128.
Dragon-Durey M-A, Chen X, Kirilovsky A, Hamouda NB, El Sissy C, Russick J, et al. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021;16(5):e0252026. doi: 10.1371/journal.pone.0252026.
Donamou J, Touré A, Camara AY, Camara D, Camara ML, Traoré AD, et al. Predictive factors of mortality in patients with covid-19 in Guinea: Analysis of the first 140 cases admitted to intensive care unit. Pan Afr Med J. 2021;38: 205. doi: 10.11604/pamj.2021.38.205.27078.
Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, et al. Risk and protective factors related to mortality from pneumonia among middle-aged and elderly community residents: The JACC study. J Epidemiol. 2007;17(6):194–202. doi: 10.2188/jea.17.194.
Pouwels S, Ramnarain D, Aupers E, Rutjes‐weurding L, van Oers J. Obesity may not be associated with 28‐day mortality, duration of invasive mechanical ventilation and length of intensive care unit and hospital stay in critically ill patients with severe acute respiratory syndrome coronavirus‐2: A retrospective cohort st. Medicina (Kaunas). 2021; 57(7): 674. doi: 10.3390/medicina57070674.
Kooistra EJ, de Nooijer AH, Claassen WJ, Grondman I, Janssen NAF, Netea MG, et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes. 2021;45(3):687–94. doi: 10.1038/s41366-021-00747-z.
N O, JL P, JJ L, K W. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2): 85–97. doi: 10.1038/nri2921.
Walkey AJ, Rice TW, Konter J, Ouchi N, Shibata R, Walsh K, et al. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med. 2010; 38(12): 2329-34. doi: 10.1097/CCM.0b013e3181fa0561.
Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005; 165(1): 55–61. doi:10.1001/archinte.165.1.55.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020; 323(20): 2052–9. doi: 10.1001/jama.2020.6775.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020; 382:2372-2374. Doi: 10.1056/NEJMc2010419
Faria CF, Reis RW, Ribeiro FAC, de Souza RG, Duarte GRS, Barroso WA. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes Metab Syndr. 2020; 14(5): 809-814. doi: 10.1016/j.dsx.2020.06.016.
Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020; 28(7): 1195-1199. doi: 10.1002/oby.22831.
Chen TL, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical characteristics and outcomes of older patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020; 75(9): 1788-1795. doi: 10.1093/gerona/glaa089.
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323(18): 1775-1776. doi: 10.1001/jama.2020.4683.
Descargas
Publicado
Versiones
- 2021-06-30 (2)
- 2021-06-30 (1)
Número
Sección
Licencia
Derechos de autor 2021 Interdisciplinary Journal of Epidemiology and Public Health
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
-
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
